OBJECTIVE: Xenotransplantation using pig organs could end the donor organ shortage for transplantation, but humans have xenoreactive antibodies that cause early graft rejection. Genome editing can eliminate xenoantigens in donor pigs to minimize the impact of these xenoantibodies. Here we determine whether an improved cross-match and chemical immunosuppression could result in prolonged kidney xenograft survival in a pig-to-rhesus preclinical model. METHODS: Double xenoantigen (Gal and Sda) knockout (DKO) pigs were created using CRISPR/Cas. Serum from rhesus monkeys (n = 43) was cross-matched with cells from the DKO pigs. Kidneys from the DKO pigs were transplanted into rhesus monkeys (n = 6) that had the least reactive cross-matches. The rhesus recipients were immunosuppressed with anti-CD4 and anti-CD8 T-cell depletion, anti-CD154, mycophenolic acid, and steroids. RESULTS: Rhesus antibody binding to DKO cells is reduced, but all still have positive CDC and flow cross-match. Three grafts were rejected early at 5, 6, and 6 days. Longer survival was achieved in recipients with survival to 35, 100, and 435 days. Each of the 3 early graft losses was secondary to IgM antibody-mediated rejection. The 435-day graft loss occurred secondary to IgG antibody-mediated rejection. CONCLUSIONS: Reducing xenoantigens in donor pigs and chemical immunosuppression can be used to achieve prolonged renal xenograft survival in a preclinical model, suggesting that if a negative cross-match can be obtained for humans then prolonged survival could be achieved.
OBJECTIVE: Xenotransplantation using pig organs could end the donor organ shortage for transplantation, but humans have xenoreactive antibodies that cause early graft rejection. Genome editing can eliminate xenoantigens in donorpigs to minimize the impact of these xenoantibodies. Here we determine whether an improved cross-match and chemical immunosuppression could result in prolonged kidney xenograft survival in a pig-to-rhesus preclinical model. METHODS: Double xenoantigen (Gal and Sda) knockout (DKO) pigs were created using CRISPR/Cas. Serum from rhesus monkeys (n = 43) was cross-matched with cells from the DKO pigs. Kidneys from the DKO pigs were transplanted into rhesus monkeys (n = 6) that had the least reactive cross-matches. The rhesus recipients were immunosuppressed with anti-CD4 and anti-CD8 T-cell depletion, anti-CD154, mycophenolic acid, and steroids. RESULTS: Rhesus antibody binding to DKO cells is reduced, but all still have positive CDC and flow cross-match. Three grafts were rejected early at 5, 6, and 6 days. Longer survival was achieved in recipients with survival to 35, 100, and 435 days. Each of the 3 early graft losses was secondary to IgM antibody-mediated rejection. The 435-day graft loss occurred secondary to IgG antibody-mediated rejection. CONCLUSIONS: Reducing xenoantigens in donorpigs and chemical immunosuppression can be used to achieve prolonged renal xenograft survival in a preclinical model, suggesting that if a negative cross-match can be obtained for humans then prolonged survival could be achieved.
Authors: Laura Higginbotham; Dave Mathews; Cynthia A Breeden; Mingqing Song; Alton Brad Farris; Christian P Larsen; Mandy L Ford; Andrew J Lutz; Matthew Tector; Kenneth A Newell; A Joseph Tector; Andrew B Adams Journal: Xenotransplantation Date: 2015-04-03 Impact factor: 3.907
Authors: T E Starzl; T L Marchioro; P I Terasaki; K A Porter; T D Faris; T J Herrmann; D L Vredevoe; M P Hutt; D A Ogden; W R Waddell Journal: Ann Surg Date: 1965-10 Impact factor: 12.969
Authors: Gang Chen; Hua Qian; Thomas Starzl; Hongtao Sun; Bertha Garcia; Ximo Wang; Yishai Wise; Yuanqing Liu; Ying Xiang; Laura Copeman; Weihua Liu; Anthony Jevnikar; William Wall; David K C Cooper; Noriko Murase; Yifan Dai; Wanyu Wang; Yuliang Xiong; David J White; Robert Zhong Journal: Nat Med Date: 2005-11-27 Impact factor: 53.440
Authors: Andrew J Lutz; Ping Li; Jose L Estrada; Richard A Sidner; Ray K Chihara; Susan M Downey; Christopher Burlak; Zheng-Yu Wang; Luz M Reyes; Bess Ivary; Fuqin Yin; Ross L Blankenship; Leela L Paris; A Joseph Tector Journal: Xenotransplantation Date: 2013 Jan-Feb Impact factor: 3.907
Authors: Guerard W Byrne; Zeji Du; Paul Stalboerger; Heide Kogelberg; Christopher G A McGregor Journal: Xenotransplantation Date: 2014-09-01 Impact factor: 3.907
Authors: Abhijit Jagdale; Huy Nguyen; Juan Li; KaLia Burnette; David Ayares; David K C Cooper; Hidetaka Hara Journal: Int J Surg Date: 2020-09-25 Impact factor: 6.071
Authors: Kannan P Samy; Qimeng Gao; Robert Patrick Davis; Mingqing Song; Zachary W Fitch; Michael S Mulvihill; Andrea L MacDonald; Frank V Leopardi; Tam How; Kyha D Williams; Gayathri R Devi; Bradley H Collins; Xunrong Luo; Allan D Kirk Journal: Xenotransplantation Date: 2019-06-20 Impact factor: 3.907